- Home
- FNA
FNA
Paragon 28 Inc.
as 07-26-2024 4:00pm EST
Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | ENGLEWOOD |
| Market Cap: | 635.4M | IPO Year: | 2021 |
| Target Price: | $16.75 | AVG Volume (30 days): | 568.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.64 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.55 - $17.85 | Next Earning Date: | 08-08-2024 |
| Revenue: | $225,435,000 | Revenue Growth: | 17.38% |
| Revenue Growth (this year): | 21.52% | Revenue Growth (next year): | -1.78% |
Stock Insider Trading Activity of Paragon 28 Inc. (FNA)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| DaCosta Albert | FNA | See Remarks | Mar 15 '24 | Buy | $9.12 | 28,000 | $255,225.60 | 5,339,110 | SEC Form 4 |
| DaCosta Albert | FNA | see remarks | Nov 10 '23 | Buy | $8.51 | 30,500 | $259,555.00 | 5,311,110 | SEC Form 4 |
Latest Paragon 28 Inc. News
FNA Breaking Stock News: Dive into FNA Ticker-Specific Updates for Smart Investing
Simply Wall St.
9 hours ago
This Paragon 28 Insider Increased Their Holding In The Last Year
Business Wire
9 days ago
Paragon 28 to Report Second Quarter 2024 Financial Results on August 8, 2024
Insider Monkey
2 months ago
Paragon 28, Inc. (NYSE:FNA) Q1 2024 Earnings Call Transcript
GuruFocus.com
3 months ago
Paragon 28 Inc (FNA) Q1 2024 Earnings: Aligns with Revenue Projections and Reaffirms Full-Year ...
MT Newswires
3 months ago
Piper Sandler Adjusts Price Target on Paragon 28 to $15 From $18, Maintains Overweight Rating
Thomson Reuters StreetEvents
3 months ago
Q1 2024 Paragon 28 Inc Earnings Call
Business Wire
3 months ago
Paragon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue Guidance
Business Wire
3 months ago
Paragon 28 to Present at the Bank of America Securities 2024 Healthcare Conference
Compare FNA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "FNA Paragon 28 Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.